Literature DB >> 11702847

Prenatal diagnosis and follow up of biliary atresia.

L Burc1, E Vuillard, J Guibourdenche, M Conti, C Garel, D Porquet, J F Oury, D Luton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11702847     DOI： 10.1111/j.1471-0528.2001.00255.x

Source DB:  PubMed          Journal:  BJOG        ISSN： 1470-0328            Impact factor:   6.531


× No keyword cloud information.
  6 in total

1.  Biliary Atresia as a Disease Starting In Utero: Implications for Treatment, Diagnosis, and Pathogenesis.

Authors:  Krupa R Mysore; Benjamin L Shneider; Sanjiv Harpavat
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-10       Impact factor: 2.839

2.  Periductal bile acid exposure causes cholangiocyte injury and fibrosis.

Authors:  Miri Dotan; Sophia Fried; Adi Har-Zahav; Raanan Shamir; Rebecca G Wells; Orith Waisbourd-Zinman
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

3.  Prenatal ultrasound diagnosis of cystic biliary atresia.

Authors:  Baptiste Morel; Kamila Kolanska; Ferdinand Dhombres; Jean Marie Jouannic; Stéphanie Franchi-Abella; Hubert Ducou Le Pointe; Catherine Garel
Journal:  Clin Case Rep       Date:  2015-11-06

4.  Extrahepatic biliary atresia with choledochal cyst: Prenatal MRI predicted and post natally confirmed: A case report.

Authors:  Madhavi Nori; J Venkateshwarlu; G Raghavendra Prasad
Journal:  Indian J Radiol Imaging       Date:  2013-07

5.  Left atrial isomerism associated with aneurysmal enlargement of right atrial appendage: A case report with literature review.

Authors:  Prateek Agarwal; Rajesh Kumar Agarwal
Journal:  Indian J Radiol Imaging       Date:  2019-10-30

6.  Extrahepatic cholangiocyte obstruction is mediated by decreased glutathione, Wnt and Notch signaling pathways in a toxic model of biliary atresia.

Authors:  Sophia Fried; Dafna Gilboa; Adi Har-Zahav; Pierre-Marie Lavrut; Yu Du; Sara Karjoo; Pierre Russo; Raanan Shamir; Rebecca G Wells; Orith Waisbourd-Zinman
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.